e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
Launched by UNIVERSITY OF MIAMI · Mar 18, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new online program designed to help patients with pancreatic cancer manage their stress and symptoms. The goal is to find out if this program can make a positive difference in the emotional well-being of patients who are facing this challenging diagnosis.
To participate in the study, you need to be at least 18 years old and speak either Spanish or English well enough to read and complete surveys. You must have a diagnosis of pancreatic cancer, including a specific type called pancreatic neuroendocrine tumor (PNET). However, if you have a severe mental health condition or any other issues that could affect your health or participation in the study, you may not be eligible. The study is not currently recruiting patients, but it's an important step toward improving support for those dealing with pancreatic cancer. Participants will be expected to engage with the online program and share their experiences through surveys, helping researchers understand how to better support patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Greater than 18 years of age.
- • 2. Spanish or English speaker with ability to read one of these languages.
- • 3. Diagnosis of pancreatic cancer.
- • 4. Patients diagnosed with pancreatic neuroendocrine tumor (PNET).
- Exclusion Criteria:
- • 1. Patients unable to read Spanish or English, as participants will not be unable to complete surveys.
- • 2. Have a history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months).
- • 3. Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Frank Penedo, PhD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported